Tenet Healthcare (THC) Gets a Hold Rating from Stephens


Stephens analyst Scott Fidel reiterated a Hold rating on Tenet Healthcare (THC) yesterday and set a price target of $29. The company’s shares opened today at $27.16.

According to TipRanks.com, Fidel is a 5-star analyst with an average return of 14.3% and a 71.2% success rate. Fidel covers the Services sector, focusing on stocks such as WellCare Health Plans, Magellan Health, and Centene Corp.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Tenet Healthcare with a $30.13 average price target, representing a 10.9% upside. In a report released yesterday, Merrill Lynch also maintained a Hold rating on the stock with a $30 price target.

See today’s analyst top recommended stocks >>

The company has a one-year high of $39.74 and a one-year low of $16.61. Currently, Tenet Healthcare has an average volume of 1.46M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Tenet Healthcare Corp. engages in the provision of health care services. Through its subsidiaries and affiliates, it owns and facilitates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, and related health care facilities.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts